Quantcast

Latest Citeline Stories

2011-08-11 08:00:00

NEW YORK, Aug. 11, 2011 /PRNewswire/ -- Citeline, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials recently reviewed the findings from the 14th International Conference on Alzheimer's Disease (ICAD 2011/AAIC 2011) July 16-21, 2011, noting that while pharma continues to develop beta amyloid targeting drugs, amyloid targets are moving ahead in terms of biomarkers and early warning for risk of Alzheimer's. According to Dr. Revati Tatake,...

2011-06-28 07:05:00

NEW YORK, June 28, 2011 /PRNewswire/ -- Citeline, the world's leading research authority on pharmaceutical clinical trials and intelligence, recently completed its comprehensive year on year assessment of the pharmaceutical industry's drug development pipeline. Citeline's 2011 Annual Review of Trends in Pharmaceutical R&D released on June 24 found that the overall size and potential of the pharmaceutical industry, as judged by growth in its drug development pipeline, remained flat,...

2011-06-02 08:08:00

NEW YORK, June 2, 2011 /PRNewswire/ -- Citeline, the world's leading research authority on pharmaceutical clinical trials and intelligence recently completed a comprehensive review of clinical trial starts in the oncology therapeutic area to uncover trends and patterns in drug development. Over the one-year review period (October 2009 through September 2010) over 400 late stage trials were initiated in the oncology sector, more than any other therapeutic area, according to Citeline...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.